CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MELASTOP project focuses on developing new therapeutic strategies for melanoma, particularly for patients resistant to existing treatments. By targeting specific metabolic pathways and repositioning existing drugs, it aims to improve outcomes for this aggressive skin cancer.
Melanoma is the most aggressive skin tumor, extremely difficult to treat and with high mortality rate.
Overcoming reduced sensitivity and acquired resistance to targeted therapy is a major goal of current melanoma research.
Therefore, there is an urgent need for development of novel drugs that can cure and prolong the survival of melanoma patients.
Molecular targeted therapy by using a drug that reduces the growth and spread of cancer cells via inhibition of specific protein or pathway is a mile…
UNIVERSITA DEGLI STUDI DI PADOVA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
